PF-06650833
B7921005
Phase 2 small_molecule completed
Quick answer
PF-06650833 for Rheumatoid Arthritis is a Phase 2 program (small_molecule) at Pfizer with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pfizer
- Indication
- Rheumatoid Arthritis
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed